Skip to content

Author

Jiahong Zhang

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Integrated LC-MS/MS profiling, network pharmacology and experimental validation reveal inhibition of the IL-6/JAK2/STAT3 pathway by Shenqi Compound in comorbid chronic pancreatitis and type 2 diabetes mellitus.

SQC treatment is associated with the suppression of the IL-6/JAK2/STAT3 pathway, accompanied by reduced inflammation, decreased fibrosis, and improvements in both exocrine and endocrine functions in model mice, suggesting that the formula potentially acts as a holistic regulator.

Yi Su, Heng Yang, Xianrun Gong et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.